@inproceedings{inproceedings, title  = {{Updated analysis of the phase III, double-blind, randomized, multinational study of radium-223 chloride in castration-resistant prostate cancer (CRPC) patients with bone metastases (ALSYMPCA).}},

 url = {{}},

 year = {{2012}},

 month = {{5}},

 author = {{Parker C and Nilsson S and Heinrich D and O'Sullivan JM and Fossa SD and Chodacki A and Wiechno PJ and Logue JP and Seke M and Widmark A and Johannessen DC et al}},

 doi = {{10.1200/jco.2012.30.18_suppl.lba4512}},

 volume = {{30}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{15}},

 note = {{Accessed on 2025/10/10}}}